Dr. Jan De Smet

CSO

Therapeutic Areas

Drug	Indication	Phase
OMN-001	Mucopolysaccharidosis type I	Preclinical
OMN-002	Glycogen storage disease type II	Preclinical
OMN-003	Lysosomal acid lipase deficiency	Preclinical